TotalMarketCap

Pacira BioSciences

PCRXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.452 B

$36.44 +0.10%

Close of 6 Nov 2026

As of 6 Nov 2026, Pacira BioSciences (PCRX) has a market capitalization of $1.45B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$726.4M

#1702 by revenue

Earnings

$7.00M

#2110 by earnings

Shares outstanding

40,094,660

Latest filing cover page

P/E ratio

207.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #114PrecigenPGEN$1.50B
  2. #115uniQureQURE$1.47B
  3. #116Pacira BioSciencesPCRX$1.45B
  4. #117Phibro Animal HealthPAHC$1.44B
  5. #118Tyra BiosciencesTYRA$1.43B

What if Pacira BioSciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$708,367.73

Per share 19,442× higher

Bitcoin $1.53T

$38,328.54

Per share 1,052× higher

Apple $5.02T

$125,829.03

Per share 3,454× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Pacira BioSciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.